Judge Cuts 2nd Cymbalta Trial Short With Verdict For Lilly

Law360, New York (August 13, 2015, 2:39 PM EDT) -- Eli Lilly & Co. on Thursday defeated claims that it concealed the withdrawal risks of its antidepressant Cymbalta when a California federal judge cut short a trial and issued a directed verdict for the drugmaker, less than a week after jurors in another California suit cleared the company.

U.S. District Judge Stephen V. Wilson issued a directed verdict Thursday ending the trial, following the close of plaintiff Erin Hexum's case-in-chief late Wednesday, according to a court transcript. Judge Wilson on Thursday morning told the parties he understood the arguments they made Wednesday and, without hearing further argument, granted Eli Lilly's motion...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS